BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will serve on the International Finance Panel at BioContact 2007 on October 3, 2007 in Quebec City
News | 10. 03. 2007
